ATF Seeks Input to Simplify Firearms Disability Relief Certification Form
Published Date: 11/17/2025
Notice
Summary
The ATF is updating a form that helps states certify when someone’s gun rights are restored after a disability. This affects people involved in state relief programs and aims to make the process clearer and easier, with a 30-day comment period ending December 17, 2025. No big costs are expected, but your feedback can help improve the form and reduce hassle.
Analyzed Economic Effects
2 provisions identified: 1 benefits, 1 costs, 0 mixed.
States must certify to get NICS grants
State, local, and tribal governments must use ATF Form 3210.12 to certify that they have qualifying relief-from-disabilities programs in order to qualify for NICS Improvement Act grants. The collection is expected to involve 50 respondents, takes an estimated 15 minutes per respondent, is filed once annually, and the notice solicits comments through December 17, 2025.
Enables applicants to seek relief from firearms disability
To qualify for a grant, a state official must certify that the state has a program letting people adjudicated as a mental defective or committed to an institution apply for relief from a firearms disability. That certification process uses ATF Form 3210.12 and is part of the NICS Improvement Act-related requirements.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Related Federal Register Documents
2026-11526 — Implementation of the Substance Use-Disorder Prevention That Promotes Opioid Recovery and Treatment for Patients and Communities Act of 2018: Dispensing and Administering Controlled Substances for Medication-Assisted Treatment
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-09160 — Implementing PATRIOT Act Improvements: Contraband Cigarettes and Smokeless Tobacco
Starting June 8, 2026, new rules crack down harder on illegal cigarette and smokeless tobacco sales. The government lowered the amount that counts as smuggling from 60,000 to just 10,000 cigarettes and now includes smokeless tobacco in the crackdown. Sellers and distributors must keep better records and report more info, making it tougher to dodge the law and protect honest businesses.
2026-12143 — Importer of Controlled Substances Application: AndersonBrecon, Inc. DBA PCI Pharma Services
AndersonBrecon, Inc. DBA PCI Pharma Services wants to become an official importer of certain controlled substances, including some strong drugs like tetrahydrocannabinols. People and companies involved with these drugs can share their thoughts or ask for a hearing by July 17, 2026. This move could impact how these substances are brought into the U.S., but no costs or fees were mentioned yet.
2026-12213 — Agency Information Collection Activities; Proposed eCollection eComments Requested; Reinstatement With Change to a Previously Approved Collection Title-International Terrorism Victim Expense Reimbursement Program Application
The Department of Justice is bringing back and updating the application form for the International Terrorism Victim Expense Reimbursement Program. This affects victims of international terrorism who seek help covering their expenses. The DOJ wants your feedback by July 17, 2026, to make sure the form is clear, useful, and easy to fill out—no extra hassle or hidden costs involved!
2026-12144 — Importer of Controlled Substances Application: Wedgewood Pharmacy LLC
Wedgewood Pharmacy LLC wants to become an official importer of certain strong controlled substances, like Etorphine HCL and Thiafentanil. This affects drug manufacturers and others in the supply chain who can comment or request a hearing by July 17, 2026. No direct costs are mentioned, but the decision could impact how these drugs enter the U.S. market.
Previous / Next Documents
Previous: 2025-19990 — Considerations for Waiver Requests for pH Adjusters in Generic Drug Products Intended for Parenteral, Ophthalmic, or Otic Use; Guidance for Industry; Availability
The FDA just released new guidance to help companies making generic injectable, eye, or ear medicines when they want to change the pH adjusters from the original drug. This makes it clearer how to ask for permission to use different pH adjusters, speeding up approvals and possibly saving money. The guidance is effective starting November 17, 2025, so drug makers should get ready to follow these new rules.
Next: 2025-19993 — PT. Multistrada Arah Sarana Tbk, Denial of Petition for Decision of Inconsequential Noncompliance
PT. Multistrada Arah Sarana (MASA) makes over 1.6 million Achilles, Corsa, Radar, and Milestar tires that don’t fully meet safety rules. MASA asked the government to ignore this problem, but the National Highway Traffic Safety Administration said no. This means MASA must follow all safety fix and recall rules, which could affect tire owners and costs.